Andrew D'Silva
Stock Analyst at B. Riley Securities
(1.98)
# 1,254
Out of 4,654 analysts
28
Total ratings
62.5%
Success rate
88.67%
Average return
Main Sectors:
Stocks Rated by Andrew D'Silva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OTRK Ontrak | Downgrades: Neutral | $1,350 | $1.78 | +75,742.70% | 2 | Aug 20, 2021 | |
| MPLN MultiPlan | Initiates: Buy | $400 | $7.07 | +5,557.71% | 1 | Apr 7, 2021 | |
| CYRX Cryoport | Maintains: Buy | $69 → $81 | $7.38 | +997.56% | 4 | Feb 10, 2021 | |
| GERN Geron | Maintains: Buy | $3.5 → $4 | $3.71 | +7.82% | 3 | May 29, 2020 | |
| CRMD CorMedix | Maintains: Buy | $10 → $12 | $11.00 | +9.09% | 3 | May 12, 2020 | |
| OPRX OptimizeRx | Maintains: Buy | $18 → $22 | $4.06 | +441.87% | 4 | May 5, 2020 | |
| EDAP EDAP TMS | Initiates: Buy | $5.5 | $2.52 | +118.25% | 1 | Apr 15, 2020 | |
| HROW Harrow | Maintains: Buy | $12 → $10 | $42.86 | -76.67% | 2 | Apr 7, 2020 | |
| EYPT EyePoint Pharmaceuticals | Downgrades: Neutral | $40 → $10 | $10.49 | -4.67% | 1 | Apr 6, 2020 | |
| CPIX Cumberland Pharmaceuticals | Maintains: Buy | $9 → $9.75 | $1.20 | +712.50% | 4 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $93 | $151.97 | -39.13% | 2 | Aug 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $2.34 | +756.53% | 1 | Dec 11, 2017 |
Ontrak
Aug 20, 2021
Downgrades: Neutral
Price Target: $1,350
Current: $1.78
Upside: +75,742.70%
MultiPlan
Apr 7, 2021
Initiates: Buy
Price Target: $400
Current: $7.07
Upside: +5,557.71%
Cryoport
Feb 10, 2021
Maintains: Buy
Price Target: $69 → $81
Current: $7.38
Upside: +997.56%
Geron
May 29, 2020
Maintains: Buy
Price Target: $3.5 → $4
Current: $3.71
Upside: +7.82%
CorMedix
May 12, 2020
Maintains: Buy
Price Target: $10 → $12
Current: $11.00
Upside: +9.09%
OptimizeRx
May 5, 2020
Maintains: Buy
Price Target: $18 → $22
Current: $4.06
Upside: +441.87%
EDAP TMS
Apr 15, 2020
Initiates: Buy
Price Target: $5.5
Current: $2.52
Upside: +118.25%
Harrow
Apr 7, 2020
Maintains: Buy
Price Target: $12 → $10
Current: $42.86
Upside: -76.67%
EyePoint Pharmaceuticals
Apr 6, 2020
Downgrades: Neutral
Price Target: $40 → $10
Current: $10.49
Upside: -4.67%
Cumberland Pharmaceuticals
Dec 3, 2019
Maintains: Buy
Price Target: $9 → $9.75
Current: $1.20
Upside: +712.50%
Aug 24, 2018
Maintains: Buy
Price Target: $81 → $93
Current: $151.97
Upside: -39.13%
Dec 11, 2017
Reinstates: Buy
Price Target: $20
Current: $2.34
Upside: +756.53%